Patients with metastatic colorectal cancer who received frontline immune checkpoint inhibitor therapy had positive OS rates ...

Lymph node metastasis was uncommon among clinically node-negative PTC patients without evidence of nodal involvement on USG and CT.

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...